PRESS DIGEST-Financial Times - Jan 21

Reuters
01/21
PRESS DIGEST-Financial Times - Jan 21

Jan 21 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.

Headlines

Three Ireland owner in talks over sale to Liberty Global

GSK to buy U.S. biotech behind food allergy drug for $2.2 billion

Renault to team up with French defence group to make drones for Ukraine

Independent to take over operations of London's Standard

Overview

CK Hutchison 0001.HK is in talks to sell its Irish mobile operator to Liberty Global LBTYA.O as the Hong Kong-based conglomerate continues to offload its European telecoms businesses.

GSK GSK.L has agreed to acquire Rapt Therapeutics RAPT.O, a US-based biotech whose leading drug combats food allergies, in a deal that values the company at $2.2 billion.

Renault RENA.PA has reached a deal with a French defence company Turgis Gaillard to make drones for Ukraine, in a move backed by France's defence ministry to support Kyiv against Russian aggression.

The UK's Independent Media is in advanced talks to take over the digital and commercial operations of loss making London newspaper The Standard.

(Compiled by Bengaluru newsroom)

((globalnewsmonitoring@thomsonreuters.com))

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10